Skip to main content
PW Medtech Group Limited logo

PW Medtech Group Limited — Investor Relations & Filings

Ticker · 1358 ISIN · KYG7306W1087 LEI · 894500L18EYHNJR6VJ41 HKEX Manufacturing
Filings indexed 789 across all filing types
Latest filing 2014-12-03 Capital/Financing Update
Country KY Cayman Islands
Listing HKEX 1358

About PW Medtech Group Limited

http://www.pwmedtech.com

PW Medtech Group Limited is a medical device company engaged in the research, development, production, and sale of advanced infusion therapy products. The company's core portfolio includes specialized infusion sets and related accessories, such as non-PVC and DEHP-free infusion systems, precision filter infusion sets, light-resistant infusion sets, and safety IV catheters. Operating primarily in China, India, the Americas, and Africa, the Group emphasizes patient and clinician safety. Key innovations include positive pressure needleless connectors designed to prevent blood backflow and contamination, and safety-engineered devices utilizing double-layer tubing (TPU/PVC) and high-precision filtration to mitigate needlestick injuries and adverse infusion reactions.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2014
Capital/Financing Update Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/11/2014, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related activities. The content is focused on share capital changes and movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, typical of a capital/financing update. The document is lengthy (over 12,000 characters) and contains detailed data on share capital changes, not just an announcement or summary. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2014-12-03 English
VOLUNTARY ANNOUNCEMENT - BOARD AUTHORISATION FOR EXERCISE OF THE REPURCHASE MANDATE
Transaction in Own Shares Classification · 100% confidence The document is a voluntary announcement by PW Medtech Group Limited regarding the Board's authorization to exercise the repurchase mandate to buy back shares. It references the general mandate granted at the AGM and details the Board's decision to utilize funds for on-market repurchases. The document does not contain financial statements or detailed financial data but is an announcement about share repurchase activity. This fits the category of a Transaction in Own Shares (POS) filing, which covers company announcements about buying back or selling its own shares.
2014-12-02 English
PROFIT ALERT
Earnings Release Classification · 95% confidence The document is titled 'PROFIT ALERT' and is an announcement by PW Medtech Group Limited regarding a preliminary review of unaudited management accounts indicating an expected increase in adjusted net profit for the year ending 31 December 2014. It explicitly states that the final audited results are still being finalized and will be published later in the annual report. The document is relatively short (4134 characters) and serves as a cautionary announcement to shareholders and investors about expected financial performance before the official results are released. It does not contain actual audited financial statements or detailed financial data, but rather a preliminary profit alert. This fits the profile of an Earnings Release (ER) as it is an initial announcement of financial results highlights, not a full annual report or interim report. Therefore, the appropriate classification is Earnings Release (ER). FY 2014
2014-12-02 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2014
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/10/2014, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content is focused on share capital changes and movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, typical of a capital or shareholding update. The document is not an announcement of a report, nor is it a full financial report or earnings release. It fits best under the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes.
2014-11-03 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2014
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/09/2014, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised and issued share capital, share options, warrants, convertibles, and other share-related activities. The content focuses on share capital changes and movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month. The document is not an announcement of a report but a detailed monthly return. This fits the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes.
2014-10-08 English
Interim Report 2014
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report 2014' and contains detailed financial data and analysis for the six months ended June 30, 2014. It includes sections such as Management Discussion and Analysis, Financial Review, condensed consolidated financial statements, and notes to the condensed consolidated financial information. The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year clearly indicates this is an interim or quarterly report. The document length is substantial (15,000 characters), and it is not merely an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2014
2014-09-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.